With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

Explore how researchers developed a new method for freezing iPS cells without losing their undifferentiated state.

Osteoarthritis is one of the most expensive and disabling conditions in modern medicine, driving joint replacements and ...

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...

Fate Therapeutics' off-the-shelf cell therapy product platform, including FT819, is gaining significant exposure by being selected for an oral presentation at the prominent EULAR 2025 congress. The ...

The International Society for Stem Cell Research (ISSCR) today announced the 10 most downloaded papers of 2025 from Stem Cell ...

EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its longevity and ...

Canine induced pluripotent stem (iPS) cells possess the ability to differentiate into any type of cell, making them a useful ...